Related Experiment Video
Updated: May 23, 2026

11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Diversity of matriptase expression level and function in breast cancer
Arkadiusz Welman1, Duncan Sproul, Peter Mullen
1Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, Scotland, United Kingdom. A.Welman@ed.ac.uk
Plos One
|April 20, 2012
Summary
Matriptase overexpression in breast cancer shows variable effects. Its role appears context-dependent, potentially linked to HER2 status and impacting cell adhesion and growth differently across cell types.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Matriptase overexpression is linked to various human cancers and tumor formation in mice.
- The specific role and significance of matriptase in human breast cancer remain largely undetermined.
Purpose of the Study:
- To investigate the expression levels and functional consequences of matriptase in human breast cancer.
- To determine if matriptase expression correlates with specific breast cancer subtypes, such as HER2-positive cases.
Main Methods:
- Analysis of matriptase protein expression in 16 human breast cancer cell lines and 107 primary breast tumors.
- Stable overexpression of matriptase in MDA-MB-231 and 4T1 breast cancer cell lines.
- Assessment of cell morphology, actin cytoskeleton, cell-cell contacts, and E-cadherin expression.
Main Results:
- Matriptase expression levels varied significantly across breast cancer samples, suggesting case-to-case variability.
- Matriptase protein expression positively correlated with HER2 expression, particularly in HER2-positive cell lines.
- Matriptase overexpression impaired growth in MDA-MB-231 cells but altered morphology and reduced E-cadherin in 4T1 cells.
Conclusions:
- Matriptase's function in breast cancer is cell context-dependent and likely varies based on the specific tumor characteristics.
- The correlation with HER2 suggests a potential role for matriptase in HER2-positive breast cancer subgroups.
- Further research is needed to elucidate the precise mechanisms and therapeutic implications of matriptase in different breast cancer settings.
